CENTENE CORP
Government Contracts & Awards
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Can Centene Sustain Its Turnaround Amid Membership Pressure?
CNC's profitability is recovering, but rising margins face a key test as Medicaid membership declines and eligibility reviews continue.
Can Centene's Medicare Advantage Strategy Unlock Better Margins?
CNC is set to reshape its Medicare Advantage business around dual-eligible members and a simpler footprint to drive margin recovery.
How Can Healthcare Inflation Fuel Growth for MRSH, UNH & CNC?
Rising employer healthcare costs could boost Marsh's consulting demand and create growth avenues for UnitedHealth and Centene through cost-control solutions.
Can Centene's Marketplace Recovery Fuel Stronger Earnings Growth?
CNC's Marketplace recovery is boosting profitability as better pricing, medical cost trends and risk dynamics reshape its earnings outlook.
Oakmark Concentrated Strategy Q2 2026 Performance Review
Centene, ICON and Keurig Dr Pepper were the contributors during the quarter. Read more here.
Centene: H2 2026 May Disappoint, Potential Buying Opportunity Ahead
Centene outlook: premium repricing boosts HBR and margins; watch Medicaid/Stars-driven attrition risks into 2026â27. See more on CNC stock here.
Centene: Why Declining Membership Could Actually Be A Bullish Sign
Centene (CNC) is repositioning after a major guidance withdrawal and reputational setback tied to Marketplace morbidity miscalculations.
Why Centene (CNC) Is Up 8.4% After Raising 2026 Guidance and Redeeming 2027 Notes - And What's Next
Centene Corporation recently reported past second-quarter 2026 results showing revenue of US$53,579 million and net income of US$1,091 million, while also announcing a partial US$500 million redemption of its 4.25% Notes due 2027 and leadership changes on its board. The company’s raised full-year 2026 revenue and earnings guidance, alongside institutional investor focus on Medicaid margin recovery, has sharpened attention on its managed care profitability trajectory. Now we’ll examine how...
UnitedHealth vs. Centene: Which Managed Care Stock Is the Better Buy?
UNH's diversified platform, AI expansion and Optum momentum strengthen its long-term outlook, making it the stronger managed care pick over CNC.
Centene Q2 Earnings Beat Estimates on Increasing Premiums
CNC's Q2 earnings and revenues top estimates as stronger premium and service revenues drive results despite lower membership and higher medical costs.
Congressional Trades in $CNC
Insider Trades (Form 4)
PIENKOS THEODORE J
Tyler Lauren M
Tyler Lauren M
TANJI KENNETH
Samuels Theodore R. II
EPPINGER FREDERICK H
COUGHLIN CHRISTOPHER J
SMITH SUSAN RAYE
Key People
PIENKOS THEODORE J
Corporate Controller & CAO
EPPINGER FREDERICK H
Director
Samuels Theodore R
Director
Tyler Lauren M
Director
COUGHLIN CHRISTOPHER J
Director
TANJI KENNETH
Director
SMITH SUSAN RAYE
Chief Operating Officer
Political Giving
$199,226 given to 60 candidates across 121 disclosed contributions (FEC Schedule A).
Bradley S. Schneider
Darin McKay LaHood
Ann Wagner
James French Hill
Katherine M. Clark
David P. Joyce
Terri A. Sewell
Scott H. Peters
Gus M. Bilirakis
Greg Steube
Shelley Moore Capito
Max Miller
Frank Pallone
Markwayne Mullin
Earl Blumenauer
John Curtis
Josh Gottheimer
Blake Moore
Susan M. Collins
Adam Smith
+ 40 more recipients not shown.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro